Hmmm... the page you're looking for isn't here. Try searching above.
- EntertainmentCosmo
I'm A Celeb has now received more than 700 Ofcom complaints
200 people complained over the second episode
- PoliticsHuffPost
Washington Post Editorial Board Tears Into Donald Trump: 'A Total Disgrace'
The newspaper's board rebuked the president for pardoning his former adviser, Michael Flynn.
- EntertainmentYahoo Celebrity UK
Mystery as contestant edited out of 'MasterChef: The Professionals'
Viewers have been speculating about the missing chef.
- NewsYahoo News UK
What tier are you in? Here is the full list of lockdown restrictions for each area
The government has announced which coronavirus tiers each area of England will be in after the national lockdown ends on 2 December.
- PoliticsThe Independent
Trump pushing through dozens of last minute policy changes – including use of firing squads
Five more federal executions are scheduled in the weeks before Joe Biden enters the White House
- NewsSky News
COVID-19: 'Don't hug your gran at Christmas' - Prof Chris Whitty's message as Boris Johnson warns of New Year lockdown
Boris Johnson has raised the prospect of a New Year lockdown if Britons ease off in the fight against coronavirus - as his chief medic warned people not to hug elderly relatives at Christmas. England is due to exit its second national lockdown next Wednesday and the prime minister, speaking at a Downing Street news conference, said his aim now was to avoid "taking our foot off the throat of the beast". "If we ease off now we risk losing control of this virus all over again, casting aside our hard-won gains and forcing us back to a New Year national lockdown with all the damage that would mean," he said.
- HealthThe Telegraph
Manufacturing error clouds Oxford's Covid-19 vaccine study results
Oxford University and AstraZeneca on Wednesday acknowledged a manufacturing error that is raising questions about preliminary results of their experimental Covid-19 vaccine. A statement describing the error came days after the company and the university described the shots as "highly effective" and made no mention of why some study participants did not receive as much vaccine in the first of two shots as expected. In a surprise finding, the group of volunteers that got a lower dose seemed to be much better protected than the volunteers who got two full doses. In the low-dose group, AstraZeneca said, the vaccine appeared to be 90 per cent effective. In the group that got two full doses, the vaccine appeared to be 62 per cent effective. Combined, the drugmakers said the vaccine appeared to be 70 per cent effective, but the way in which the results were arrived at and reported by the companies has led to pointed questions from experts. The partial results announced on Monday are from large ongoing studies in the UK and Brazil designed to determine the optimal dose of vaccine as well as examine safety and effectiveness. Multiple combinations and doses were tried in the volunteers, and they were compared to others who were given a meningitis vaccine or a saline shot.
